Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
MiNK Therapeutics, Inc. (INKT) had Debt to Capital Ratio of -0.34 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-10.78M |
|
-- |
|
-- |
|
$10.01M |
|
$-10.01M |
|
$0.50M |
|
$-9.51M |
|
$-9.51M |
|
$-9.51M |
|
$-9.51M |
|
$-9.51M |
|
$-9.51M |
|
$-10.01M |
|
$-9.80M |
|
3.77M |
|
3.77M |
|
$-2.86 |
|
$-2.86 |
|
| Balance Sheet Financials | |
$4.99M |
|
$0.73M |
|
$0.73M |
|
$5.72M |
|
$6.96M |
|
$4.92M |
|
$18.35M |
|
$25.31M |
|
$-19.59M |
|
$-19.59M |
|
$-19.59M |
|
3.96M |
|
| Cash Flow Statement Financials | |
$-9.56M |
|
-- |
|
$10.82M |
|
$3.37M |
|
$4.58M |
|
$1.21M |
|
$1.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.72 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-0.34 |
-0.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
48.55% |
|
48.55% |
|
-166.21% |
|
64.86% |
|
$-4.94 |
|
$-2.53 |
|
$-2.53 |
|